OJVM  Vol.4 No.9 , September 2014
Pituitary Lesions, Obesity, and Mesenteric Lipomas in Insulin-Resistant Horses
Abstract: The aim of the current study was to identify associations between pituitary lesions, body condition scores, and mesenteric lipomas in horses with insulin resistance. Necropsy examinations were performed following euthanasia in 30 adult horses designated as insulin resistant (n = 11) or insulin sensitive (n = 19). Insulin sensitivity was determined using the insulin-modified frequently sampled intravenous glucose tolerance test and resting insulin concentrations. At necropsy, mesenteric lipomas were measured. The pituitary and adrenal glands, pancreas, and liver were evaluated histologically; pituitary glands were scored based on published criteria. Insulin-resistant horses had significantly higher pituitary scores (p = 0.0035) and body condition scores (p = 0.0001), even when adjusting for age, and a greater frequency of mesenteric lipomas (p = 0.014) and greater lipoma area (p = 0.0332) than insulin-sensitive horses. Regardless of insulin status, horses with pituitary scores ≥3 (diffuse hyperplasia; n = 25) had higher body condition scores (p = 0.0313) and a greater frequency of mesenteric lipomas (p < 0.0002) than those with lower pituitary scores. High body condition score was not correlated to an increased frequency of mesenteric lipomas. Detection of higher pituitary scores in insulin-resistant horses suggested an association between insulin resistance and pituitary morphology. Horses in the insulin-resistant group and those with high pituitary scores had higher body condition scores and a greater frequency of mesenteric lipomas. These horses might be at increased risk for lipoma-associated colic.
Cite this paper: Newkirk, K. , Chameroy, K. , Tadros, E. , Rohrbach, B. and Frank, N. (2014) Pituitary Lesions, Obesity, and Mesenteric Lipomas in Insulin-Resistant Horses. Open Journal of Veterinary Medicine, 4, 190-196. doi: 10.4236/ojvm.2014.49022.

[1]   Kahn, C.R. (1978) Insulin Resistance, Insulin Insensitivity, and Insulin Unresponsiveness: A Necessary Distinction. Metabolism, 27, 1893-1902.

[2]   Bergman, R.N., Phillips, L.S. and Cobelli, C. (1981) Physiologic Evaluation of Factors Controlling Glucose Tolerance in Man: Measurement of Insulin Sensitivity and Beta-Cell Glucose Sensitivity from the Response to Intravenous Glucose. The Journal of Clinical Investigation, 68, 1456-1467.

[3]   Boston, R.C., Stefanovski, D., Moate, P.J., Sumner, A.E., Watanabe, R.M. and Bergman, R.N. (2003) MINMOD Millennium: A Computer Program to Calculate Glucose Effectiveness and Insulin Sensitivity from the Frequently Sampled Intravenous Glucose Tolerance Test. Diabetes Technology & Therapeutics, 5, 1003-1015.

[4]   Treiber, K.H., Kronfeld, D.S. and Geor, R.J. (2006) Insulin Resistance in Equids: Possible Role in Laminitis. Journal of Nutrition, 136, S2094-S2098.

[5]   Firshman, A.M. and Valberg, S.J. (2007) Factors Affecting Clinical Assessment of Insulin Sensitivity in Horses. Equine Veterinary Journal, 39, 567-575.

[6]   Hoffman, R.M., Boston, R.C., Stefanovski, D., Kronfeld, D.S. and Harris, P.A. (2003) Obesity and Diet Affect Glucose Dynamics and Insulin Sensitivity in Thoroughbred Geldings. Journal of Animal Science, 81, 2333-2342.

[7]   Edwards, G.B. and Proudman, C.J. (1994) An Analysis of 75 Cases of Intestinal Obstruction Caused by Pedunculated Lipomas. Equine Veterinary Journal, 26, 18-21.

[8]   Brown, C.C., Baker, D.C. and Barker, I.K. (2007) Alimentary System. In: Maxie, M.G., Ed., Jubb, Kennedy and Palmer’s Pathology of Domestic Animals, 5th Edition, Vol. 2, Saunders Elsevier, Edinburgh, 1-296.

[9]   Vincent, H.K., Innes, K.E. and Vincent, K.R. (2007) Oxidative Stress and Potential Interventions to Reduce Oxidative Stress in Overweight and Obesity. Diabetes, Obesity & Metabolism, 9, 813-839.

[10]   Suagee, J.K., Corl, B.A., Crisman, M.V., Pleasant, R.S., Thatcher, C.D. and Geor, R.J. (2013) Relationships between Body Condition Score and Plasma Inflammatory Cytokines, Insulin, and Lipids in a Mixed Population of Light-Breed Horses. Journal of Veterinary Internal Medicine, 27, 157-163.

[11]   Klinkhamer, K., Menheere, P.P.C.A. and van der Kolk, J.H. (2011) Basal Glucose Metabolism and Peripheral Insulin Sensitivity in Equine Pituitary Pars Intermedia Dysfunction. The Veterinary Quarterly, 31, 19-28.

[12]   McGowan, C.M., Frost, R., Pfeiffer, D.U. and Neiger, R. (2004) Serum Insulin Concentrations in Horses with Equine Cushing’s Syndrome: Response to a Cortisol Inhibitor and Prognostic Value. Equine Veterinary Journal, 36, 295-298.

[13]   van der Kolk, J.H., Wensing, T., Kalsbeek, H.C. and Breukink, H.J. (1995) Laboratory Diagnosis of Equine Pituitary Pars Intermedia Adenoma. Domestic Animal Endocrinology, 12, 35-39.

[14]   Donaldson, M.T., McFarlane, D., Jorgensen, A.J.R. and Beech, J. (2004) Correlation between Plasma α-Melanocyte-Stimulating Hormone Concentration and Body Mass Index in Healthy Horses. American Journal of Veterinary Research, 65, 1469-1473.

[15]   Toth, F., Frank, N., Elliott, S.B., Perdue, K., Geor, R.J. and Boston, R.C. (2009) Optimisation of the Frequently Sampled Intravenous Glucose Tolerance Test to Reduce Urinary Glucose Spilling in Horses. Equine Veterinary Journal, 41, 844-851.

[16]   Freestone, J.F., Wolfsheimer, K.J., Kamerling, S.G., Church, G., Hamra, J. and Bagwell, C. (1991) Exercise Induced Hormonal and Metabolic Changes in Thoroughbred Horses: Effects of Conditioning and Acepromazine. Equine Veterinary Journal, 23, 219-223.

[17]   Heinrichs, M., Baumgartner, W. and Capen, C.C. (1990) Immunocytochemical Demonstration of Proopiomelanocortin-Derived Peptides in Pituitary Adenomas of the Pars Intermedia in Horses. Veterinary Pathology, 27, 419-425.

[18]   Miller, M.A., Pardo, I.D., Jackson, L.P., Moore, G.E. and Sojka, J.E. (2008) Correlation of Pituitary Histomorphometry with Adrenocorticotropic Hormone Response to Domperidone Administration in the Diagnosis of Equine Pituitary Pars Intermedia Dysfunction. Veterinary Pathology, 45, 26-38.

[19]   Hardy, O.T., Czech, M.P. and Corvera, S. (2012) What Causes the Insulin Resistance Underlying Obesity? Current Opinions in Endocrinology, Diabetes, and Obesity, 19, 81-87.

[20]   Tadros, E.M. and Frank, N. (2011) Endocrine Disorders and Laminitis. Equine Veterinary Education, 25, 152-162.

[21]   Frank, N., Geor, R.J., Bailey, S.R., Durham, A.E. and Johnson, P.J. (2010) Equine Metabolic Syndrome. Journal of Veterinary Internal Medicine, 24, 467-475.

[22]   McFarlane, D. (2011) Equine Pituitary Pars Intermedia Dysfunction. Veterinary Clinics of North America: Equine Practice, 27, 93-113.

[23]   McFarlane, D., Dybdal, N., Donaldson, M.T., Miller, L. and Cribb, A.E. (2005) Nitration and Increased α-Synuclein Expression Associated with Dopaminergic Neurodegeneration in Equine Pituitary Pars Intermedia Dysfunction. Journal of Neuroendocrinology, 17, 73-80.

[24]   Carter, R.A., McCutcheon, L.J., George, L.A., Smith, T.L., Frank, N. and Geor, R.J. (2009) Effects of Diet-Induced Weight Gain on Insulin Sensitivity and Plasma Hormone and Lipid Concentrations in Horses. American Journal of Veterinary Research, 70, 1250-1258.

[25]   van der Kolk, J.H., Heinrichs, M., van Amerongen, J.D., Stooker, R.C.J., Jansen in de Wal, L. and van den Ingh, T.S.G.A.M. (2004) Evaluation of Pituitary Gland Anatomy and Histopathologic Findings in Clinically Normal Horses and Horses and Ponies with Pituitary Pars Intermedia Adenoma. American Journal of Veterinary Research, 65, 1701- 1707.